Kodiak Sciences Statistics
Share Statistics
Kodiak Sciences has 52.76M
shares outstanding. The number of shares has increased by 0.17%
in one year.
| Shares Outstanding | 52.76M |
| Shares Change (YoY) | 0.17% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 79.92% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 381 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 3.36M, so 6.37% of the outstanding
shares have been sold short.
| Short Interest | 3.36M |
| Short % of Shares Out | 6.37% |
| Short % of Float | 10.33% |
| Short Ratio (days to cover) | 6.74 |
Valuation Ratios
The PE ratio is -2.97 and the forward
PE ratio is -1.09.
Kodiak Sciences's PEG ratio is
0.09.
| PE Ratio | -2.97 |
| Forward PE | -1.09 |
| PS Ratio | 0 |
| Forward PS | 0.9 |
| PB Ratio | 3.48 |
| P/FCF Ratio | -4.44 |
| PEG Ratio | 0.09 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Kodiak Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.72,
with a Debt / Equity ratio of 0.47.
| Current Ratio | 6.72 |
| Quick Ratio | 6.72 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | -0.47 |
| Debt / FCF | -0.6 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,616,577.98 |
| Employee Count | 109 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 34.01% in the
last 52 weeks. The beta is 2.28, so Kodiak Sciences's
price volatility has been higher than the market average.
| Beta | 2.28 |
| 52-Week Price Change | 34.01% |
| 50-Day Moving Average | 3.39 |
| 200-Day Moving Average | 4.64 |
| Relative Strength Index (RSI) | 54.78 |
| Average Volume (20 Days) | 419,033 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -186.85M |
| Net Income | -176.21M |
| EBITDA | -149.5M |
| EBIT | -176.21M |
| Earnings Per Share (EPS) | -3.35 |
Full Income StatementBalance Sheet
The company has 168.07M in cash and 70.34M in
debt, giving a net cash position of 97.73M.
| Cash & Cash Equivalents | 168.07M |
| Total Debt | 70.34M |
| Net Cash | 97.73M |
| Retained Earnings | -1.33B |
| Total Assets | 297.91M |
| Working Capital | 111.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -117.32M
and capital expenditures -400K, giving a free cash flow of -117.72M.
| Operating Cash Flow | -117.32M |
| Capital Expenditures | -400K |
| Free Cash Flow | -117.72M |
| FCF Per Share | -2.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
